Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1
F André, E M Ciruelos, D Juric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
H von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
H von der Maase, S W Hansen, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
P F Conte, M V Dieci, G Bisagni, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group
K Aabo, M Adams, P Adnitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
Cancer Treatment Reviews
|
June 21, 2025
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]
L Cortesi, F Miglietta, L Arecco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2019
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
V Guarneri, M V Dieci, G Bisagni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1
F André, E M Ciruelos, D Juric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
H von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
H von der Maase, S W Hansen, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
P F Conte, M V Dieci, G Bisagni, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group
K Aabo, M Adams, P Adnitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
Cancer Treatment Reviews
|
June 21, 2025
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]
L Cortesi, F Miglietta, L Arecco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
Page
of 20